Researchers receive NCI grant for the development of new pancreatic cancer therapies

Researchers at Washington University School of Medicine in St. Louis have received an NCI grant that will provide about $10.9 million to research programs for the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer.

Related Keywords

Lily Ramsey ,Janem Bursky ,Gregory Beatty ,William Hawkins ,Robert Schreiber ,William Gillanders ,Katrina Pedersen ,Davidg Denardo ,Researchers At Washington University School Of Medicine ,University Of Pennsylvania ,Siteman Cancer Center ,Washington University School Of Medicine ,National Institutes Of Health ,Department Of Surgery ,National Cancer Institute ,Specialized Programs Of Research Excellence ,Washington University School ,Specialized Programs ,Research Excellence ,National Institutes ,Tim Eberlein Distinguished Professor ,Surgical Oncology ,Barnes Jewish Hospital ,Kian Huat Lim ,Cancer ,Research ,Adenocarcinoma ,Chemotherapy ,Clinical Trial ,Compound ,Immune System ,Medicine ,Ncology ,Pancreatic Cancer ,Reclinical ,Surgery ,Humor ,